Literature DB >> 25207665

Quest for lead free relaxors in YIn(1-x)Fe(x)O₃ (0.0 ≤ x ≤ 1.0) system: role of synthesis and structure.

Rakesh Shukla1, Farheen N Sayed, Vinita Grover, Sudhanshu K Deshpande, Apurav Guleria, Avesh K Tyagi.   

Abstract

The B-site tailored YIn(1-x)Fe(x)O3 (0.0≤ x≤ 1.0) series was synthesized by glycine-aided gel-combustion technique and subjected to extensive structural and electrical investigations. The temperature had tremendous bearing on the phase evolution exhibited by the system. The entire system crystallized as C-type metastable polymorph in the as-synthesized form. Hexagonal polymorphs of Fe(3+)-rich compositions could be isolated by controlled heat treatment at 750 °C. Raman spectroscopic investigations showed that, while there is a general shrinkage of the lattice due to substitution of a smaller ion at In(3+)-site, there is an apparent dilation of the Y-O bond, and this anomaly reflects in the electrical behavior exhibited by the system. The single-phasic hexagonal nominal compositions, YIn(1-x)Fe(x)O3 (0.0 ≤ x ≤ 0.3), were also studied by impedance spectroscopy. The dielectric constant was found to drastically increase from 10 for YInO3 to 1000 for YIn(0.7)Fe(0.3)O3 at room temperature stressing the role of B-site tailoring on electrical behavior. More interestingly, careful substitution of Fe into YInO3 could tune the electrical behavior from a dielectric to relaxor ferroelectric in the temperature range studied. The nominal composition YIn(0.7)Fe(0.3)O3 showed a classical relaxor ferroelectric like behavior which is an important observation in context of the search for new lead free relaxor materials.

Entities:  

Year:  2014        PMID: 25207665     DOI: 10.1021/ic5009472

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  1 in total

1.  First principles study of ferroelectric hexagonal compounds RInO3 (R = Dy, Er, and Ho): electronic structure, optical and dielectric properties.

Authors:  Yifei Yu; Na Lin; Haoyuan Wang; Ran Xu; Hao Ren; Xian Zhao
Journal:  RSC Adv       Date:  2020-01-24       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.